Although generally considered safe for most people when used appropriately, its safety can depend on the method of use and individual health factors
2018;67(Sup1):1
Also published in the New England Journal of Medicine in 2022, the SURMOUNT-1 trial demonstrated that tirzepatide at the 15 mg dose produced an average weight loss of 22.5% of body weight over 72 weeks approaching results typically seen with bariatric surgery (Jastreboff et al., 2022, PMID: 35658024)
Others simply want additional metabolic support while continuing to focus on exercise, nutrition, sleep, and strength training
N-Acetyl Cysteine (NAC), a precursor of glutathione, is therefore often used instead and has been shown to successfully raise plasma glutathione levels, for example, in those with schizophrenia.[xi] Anthocyandins also recycle glutathione thus sparing it if supplemented together.[xii] NAC has plenty of evidence to support its use as a promoter of glutathione and mental health, thus reducing the brains oxidative stress